Arikah Map

Alport syndrome

Alport syndrome
Classifications and external resources
ICD-10 Q87.8
ICD-9 759.89
OMIM 301050 104200 203780 300195
DiseasesDB 454
MedlinePlus 000504
eMedicine med/110 

Alport syndrome is a genetic condition characterized by the progressive loss of kidney function and hearing. Alport syndrome can also affect the eyes. The presence of blood in the urine (hematuria) is almost always found in this condition.

It was first identified in a British family by Dr. Cecil A. Alport in 1927.


Contents

Causes

Alport syndrome is caused by mutations in COL4A3, COL4A4, and COL4A5, collagen biosynthesis genes. Mutations in any of these genes prevent the proper production or assembly of the type IV collagen network, which is an important structural component of basement membranes in the kidney, inner ear, and eye. Basement membranes are thin, sheet-like structures that separate and support cells in many tissues. When mutations prevent the formation of type IV collagen fibers, the basement membranes of the kidneys are not able to filter waste products from the blood and create urine normally, allowing blood and protein into the urine. The abnormalities of type IV collagen in kidney basement membranes cause gradual scarring of the kidneys, eventually leading to kidney failure in many people with the disease.

Inheritance patterns

Alport syndrome can have different inheritance patterns that are dependent on the genetic mutation.

Criteria for the clinical diagnosis

Gregory et al, 1996, give the following 10 criteria for the diagnosis of Alport syndrome, 4 of the 10 criteria must be met:

References

This article incorporates public domain text from The U.S. National Library of Medicine

Categories


Genetic disorders | Eponymous diseases | Nephrology

Find

Find

Find